Blogger

AIDS SURVIVORS SUMMIT SAN FRANCISCO CONVENED ON JUNE 5, 2014 NATIONAL HIV/AIDS LONG-TERM SURVIVORS AWARENESS DAY

San Francisco, CA — June 5, 2014 is the first-ever National HIV/AIDS Long-Term Survivors Awareness Day (NHALTSAD). On that day, Let’s Kick ASS—AIDS Survivor Syndrome convenes the AIDS Survivors Summit/San Francisco 2014at theSan Francisco LGBT Center on June 5, 2014 from 1:00-9:00 PM. Let’s Kick ASS is bringing together survivors, both HIV-positive and negative, with key Bay Area AIDS organizations in an effort …

AIDS SURVIVORS SUMMIT SAN FRANCISCO CONVENED ON JUNE 5, 2014 NATIONAL HIV/AIDS LONG-TERM SURVIVORS AWARENESS DAY Read More »

Bill sponsored by HIV-Positive Legislator Advances Tuesday to Help People with HIV-related Lipodystrophy

The bill was sponsored by Carl Sciortino, one of the nation’s few openly gay and openly HIV-positive legislators. The 35-year-old has since stepped down from the legislature to serve as executive director of the well-respected AIDS Action Committee. The story of the young, handsome Sciortino is remarkable in and of itself. The child of a self-proclaimed Tea Party …

Bill sponsored by HIV-Positive Legislator Advances Tuesday to Help People with HIV-related Lipodystrophy Read More »

Statin Therapy Does Not Improve Cardiovascular Risk for Patients With HIV and Low HDL

The main lipid abnormality of people living with HIV is low high density lipoprotein (HDL).  There are 5 subfractions of HDL: 2a, 2b, 3a, 3b, and 3c, from largest (and most effective in cholesterol removal) to smallest (and least effective). Neither pravastatin nor rosuvastatin changes the distribution of high-density lipoprotein (HDL) subfractions in patients who are …

Statin Therapy Does Not Improve Cardiovascular Risk for Patients With HIV and Low HDL Read More »

New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP

Healthcare providers should advise people at “substantial risk” for HIV infection about pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, or Truvada, according to new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC). This includes HIV negative people in an ongoing sexual relationship with HIV positive partners, gay or bisexual men who have had sex …

New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP Read More »

PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy.

Soft tissue augmentation with PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy. Authors Serra MS, et al.  Journal Int J STD AIDS. 2014 May 22. pii: 0956462414536878. [Epub ahead of print] Affiliation Abstract BACKGROUND: Progression of lipodystrophy syndrome is a big challenge in HIV treatment. Nowadays, fat loss at the lower part of buttocks has become another …

PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy. Read More »

The untold side of the movie “Dallas Buyers Club”

The movie Dallas Buyers Club brings attention to a little-recognized part of the AIDS activist movement: the desperate struggle to provide anything that might treat the disease when no treatment was available. AL-721, Compound Q, Peptide T—buyers clubs formed around the country to bring in potential treatments, whether pharmaceutical or botanical, for both the virus …

The untold side of the movie “Dallas Buyers Club” Read More »

Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug

For Immediate Release December 9, 2013 Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™, and Urges Rapid and Wide Dissemination of Support Program Details for Uninsured and Underinsured People Living with Hepatitis C The Fair Pricing Coalition (FPC) today condemned Gilead …

Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug Read More »

Briefing at Congress: The Changing Face of HIV/AIDS in America

Briefing:   The Changing Face of HIV/ AIDS in America September 18, 2013  Briefing: 9:30-10:30 a.m. Reception: 10:30-11 :30 a.m. US Congress Capitol Visitors Center, Room SVC 212 Hosted by: AIDS Community Research Initiative of America (ACRIA)  Services and Advocacy for GLBT Elders (SAGE)  National Hispanic Council on Aging Human Rights Campaign Gay Men’s Health Crisis …

Briefing at Congress: The Changing Face of HIV/AIDS in America Read More »

Once a Month HIV Medications – Cost Effectiveness

Long-acting antiretroviral (ARV) formulations, now in clinical development, could prolong survival in people with HIV, according to results of a modeling study [1]. But the benefit may hold true only in people with barriers to good adherence. Although long-acting antiretrovirals may not be cheap, the researchers determined they could be “a good value” when used …

Once a Month HIV Medications – Cost Effectiveness Read More »

HPV vaccine wears off quickly in HIV-positive women

Women with HIV probably need a booster shot of HPV vaccine within 2 years to maintain efficacy, according to a Canadian study of quadrivalent HPV vaccine (Gardasil) in 136 HIV-positive women. Antibody response to the vaccine is strong enough at 2 years to protect about 90% of HIV-negative women against HPV [human papillomavirus]. “But in …

HPV vaccine wears off quickly in HIV-positive women Read More »

What Can We Look Forward to in HIV Cure Research? Conversation With Research Advocate Richard Jefferys

This past March, the 20th Conference on Retroviruses and Opportunistic Infections (CROI) brought an unprecedented flurry of mainstream interest in potential HIV cure strategies. TheBodyPRO.com’s Nelson Vergel sat down with leading HIV cure research activist Richard Jefferys for an update on current important aspects, and controversies, in HIV cure research. Jefferys, who coordinates the Basic Science Vaccines …

What Can We Look Forward to in HIV Cure Research? Conversation With Research Advocate Richard Jefferys Read More »